×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [54]
内容类型
期刊论文 [54]
发表日期
2021 [2]
2020 [4]
2019 [1]
2018 [4]
2017 [4]
2016 [4]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共54条,第1-10条
帮助
限定条件
专题:上海药物研究所
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
SAF-248, a novel PI3K delta-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma
期刊论文
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 11
作者:
Zhang, Xi
;
Duan, Yu-ting
;
Wang, Yi
;
Zhao, Xing-dong
;
Sun, Yi-ming
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2021/05/24
PI3Kδ
PI3K
AKT
mTOR
diffuse large B-cell lymphoma
resistance
combination therapy
A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis
期刊论文
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 12
作者:
Liu, Yu-ting
;
Ding, Hui-hua
;
Lin, Ze-min
;
Wang, Que
;
Chen, Li
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2021/05/24
rheumatoid arthritis
BTK inhibitors
B cells
macrophages
RANKL
osteoclastogenesis
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7
作者:
Xia, Zong-jun
;
Ji, Yin-chun
;
Sun, De-qiao
;
Peng, Xia
;
Gao, Ying-lei
收藏
  |  
浏览/下载:78/0
  |  
提交时间:2020/12/21
ROS1 kinase
ROS1 inhibitor
SAF-189s
lorlatinib
crizotinib resistance
G2032R mutant
NSCLC
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 11
作者:
Su, Hai-xia
;
Yao, Sheng
;
Zhao, Wen-feng
;
Li, Min-jun
;
Liu, Jia
收藏
  |  
浏览/下载:115/0
  |  
提交时间:2020/12/24
SARS-CoV-2
3CL protease
traditional Chinese medicines
Shuanghuanglian oral liquid
baicalin
baicalein
Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells (vol 37, pg 1587, 2020)
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 2
作者:
Wang, Yue-qin
;
Shen, Ai-jun
;
Sun, Jing-ya
;
Wang, Xin
;
Liu, Hong-chun
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/07/01
EPHA2 feedback activation limits the response to PDE delta inhibition in KRAS-dependent cancer cells
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 2, 页码: 270-277
作者:
Chen, Yue-hong
;
Lv, Hao
;
Shen, Ning
;
Wang, Xiao-min
;
Tang, Shuai
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2020/07/01
KRAS
anticancer therapy
PDE delta
EPHA2
RAF
MEK
ERK signaling
PI3K alpha inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment
期刊论文
CANCER LETTERS, 2019, 卷号: 459, 页码: 145-155
作者:
Shi, Jia-jie
;
Xing, Hui
;
Wang, Yu-xiang
;
Zhang, Xi
;
Zhan, Qi-min
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2020/07/01
CYH33
Radiation
Synergism
ESCC
PI3K alpha
Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3
期刊论文
Acta pharmacologica Sinica, 2018, 卷号: 39, 期号: 12, 页码: 1885-1893
作者:
Fang, Tian
;
Liu, Dan-Dan
;
Ning, He-Ming
;
Sun, Jing-Ya
;
Huang, Xiao-Jing
收藏
  |  
浏览/下载:71/0
  |  
提交时间:2019/01/08
Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R
期刊论文
ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 11, 页码: 1768-1776
作者:
Liu, Ying-Qiang
;
Wang, Ya-Nan
;
Lu, Xiao-Yun
;
Tong, Lin-Jiang
;
Li, Yan
收藏
  |  
浏览/下载:111/0
  |  
提交时间:2019/01/08
CSF-1R
small-molecule inhibitor
macrophage
myeloid leukemia
CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
期刊论文
Acta pharmacologica Sinica, 2018
作者:
Fu, Xu-Hong
;
Zhang, Xiong
;
Yang, Hong
;
Xu, Xiao-Wei
;
Hu, Zong-Long
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/01/08
©版权所有 ©2017 CSpace - Powered by
CSpace